Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 3
2005 5
2007 1
2008 5
2009 7
2010 2
2011 6
2012 8
2013 10
2014 13
2015 14
2016 17
2017 13
2018 7
2019 4
2020 5
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Cell-penetrating peptide enhanced insulin buccal absorption.
Xu Y, Zhang X, Wang N, Pei X, Guo Y, Wang J, Barth S, Yu F, Lee SJ, He H, Yang VC. Xu Y, et al. Among authors: barth s. Int J Pharm. 2020 Jun 30;584:119469. doi: 10.1016/j.ijpharm.2020.119469. Epub 2020 May 26. Int J Pharm. 2020. PMID: 32470482
SNAP-tag technology: a general introduction.
Kolberg K, Puettmann C, Pardo A, Fitting J, Barth S. Kolberg K, et al. Among authors: barth s. Curr Pharm Des. 2013;19(30):5406-13. doi: 10.2174/13816128113199990514. Curr Pharm Des. 2013. PMID: 23431982 Review.
Applications of SNAP-tag technology in skin cancer therapy.
Padayachee ER, Adeola HA, Van Wyk JC, Nsole Biteghe FA, Chetty S, Khumalo NP, Barth S. Padayachee ER, et al. Among authors: barth s. Health Sci Rep. 2019 Jan 8;2(2):e103. doi: 10.1002/hsr2.103. eCollection 2019 Feb. Health Sci Rep. 2019. PMID: 30809593 Free PMC article. Review.
Human MAP Tau Based Targeted Cytolytic Fusion Proteins.
Akinrinmade OA, Jordaan S, Hristodorov D, Mladenov R, Mungra N, Chetty S, Barth S. Akinrinmade OA, et al. Among authors: barth s. Biomedicines. 2017 Jun 27;5(3):36. doi: 10.3390/biomedicines5030036. Biomedicines. 2017. PMID: 28653985 Free PMC article. Review.
Human Granzyme B Based Targeted Cytolytic Fusion Proteins.
Hlongwane P, Mungra N, Madheswaran S, Akinrinmade OA, Chetty S, Barth S. Hlongwane P, et al. Among authors: barth s. Biomedicines. 2018 Jun 20;6(2):72. doi: 10.3390/biomedicines6020072. Biomedicines. 2018. PMID: 29925790 Free PMC article. Review.
CD30 as a therapeutic target for lymphoma.
Schirrmann T, Steinwand M, Wezler X, Ten Haaf A, Tur MK, Barth S. Schirrmann T, et al. Among authors: barth s. BioDrugs. 2014 Apr;28(2):181-209. doi: 10.1007/s40259-013-0068-8. BioDrugs. 2014. PMID: 24043362 Review.
Targeting the fetal acetylcholine receptor in rhabdomyosarcoma.
Simon-Keller K, Barth S, Vincent A, Marx A. Simon-Keller K, et al. Among authors: barth s. Expert Opin Ther Targets. 2013 Feb;17(2):127-38. doi: 10.1517/14728222.2013.734500. Epub 2012 Dec 11. Expert Opin Ther Targets. 2013. PMID: 23231343 Review.
121 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page